Amara Therapeutics

Amara Therapeutics is an Irish digital therapeutics company focused on innovative health solutions for pelvic health, particularly overactive bladder (OAB) and female urinary incontinence.

Founded as a spin-out from the University of Galway, the company is headquartered in Newcastle, County Galway, and employs 11-20 people. The leadership team includes CEO Brendan Staunton, who has extensive experience in medical device commercialization, and COO Emma Carr. The company aims to improve care for women with incontinence by providing evidence-based behavioral therapy through its flagship product, BladderBoss, an app designed to help manage bladder health. Amara is also developing a regulated medical device for prescription use in the US and EU. Their Digital Therapeutic Platform connects patients with healthcare providers, enhancing the care experience. Amara generates revenue through subscription fees, partnerships with healthcare providers, and collaborations with insurance companies, and is actively raising capital to expand its offerings.